Quercetin Improves Behavioral Deficiencies, Restores Astrocytes and Microglia, and Reduces Serotonin Metabolism in 3-Nitropropionic Acid-Induced Rat Model of Huntington's Disease

Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress

(2013) Puneet Rinwa et al.   ARCHIVES OF PHARMACAL RESEARCH

Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis

(2013) Damineh Morsali et al.   BRAIN

Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats

(2013) S.S. Karuppagounder et al.   NEUROSCIENCE

Phenelzine (Monoamine Oxidase Inhibitor) Increases Production of Nitric Oxide and Proinflammatory Cytokines via the NF-κB Pathway in Lipopolysaccharide-Activated Microglia Cells

(2012) Hwan-Suck Chung et al.   NEUROCHEMICAL RESEARCH

Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria

(2011) Saki Yoshino et al.   NUTRITION

Altered Dopamine and Serotonin Metabolism in Motorically Asymptomatic R6/2 Mice

(2011) Fanny Mochel et al.   PLoS One

Management of Huntington’s disease: role of tetrabenazine

(2011) de Tommaso   Therapeutics and Clinical Risk Management

Dietary inhibitors of monoamine oxidase A

(2010) Sarah E. Dixon Clarke et al.   JOURNAL OF NEURAL TRANSMISSION

Resistance of Golden Hamster to l-Methyl-4-Phenyl-1,2,3,6 Tetrahydropyridine: Relationship with Low Levels of Regional Monoamine Oxidase B

(2010) N. Mitra et al.   JOURNAL OF NEUROCHEMISTRY

Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity

(2010) Jun Lu et al.   JOURNAL OF PATHOLOGY

Protective Effects of Resveratrol and Quercetin Against MPP+ -Induced Oxidative Stress Act by Modulating Markers of Apoptotic Death in Dopaminergic Neurons

(2009) Julie Bournival et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Combination therapy with Coenzyme Q10and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases

(2009) Lichuan Yang et al.   JOURNAL OF NEUROCHEMISTRY

Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats

(2009) Mritunjay Pandey et al.   NEUROCHEMISTRY INTERNATIONAL

Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation

(2009) Carole Deyts et al.   PLoS One

Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration

(2009) F. Cicchetti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Behavioural problems in Huntington's disease using the Problem Behaviours Assessment

(2008) Elisabeth M. Kingma et al.   GENERAL HOSPITAL PSYCHIATRY

Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II

(2008) Alexandra Benchoua et al.   HUMAN MOLECULAR GENETICS

Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease

(2008) Terence Y.C. Pang et al.   HUMAN MOLECULAR GENETICS

Protective effect of quercetin in primary neurons against Aβ(1–42): relevance to Alzheimer's disease

(2008) Mubeen Ahmad Ansari et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY